{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:57:54Z","timestamp":1721203074676},"reference-count":50,"publisher":"Cambridge University Press (CUP)","issue":"S1","license":[{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:p>Binge eating disorder (BED) is the most common eating disorder, with an estimated lifetime prevalence of 2.6% among U.S. adults, yet often goes unrecognized. In the<jats:italic>Diagnostic and Statistical Manual of Mental Disorders<\/jats:italic>, Fifth Edition (DSM-5), BED is defined by recurrent episodes of binge eating (eating in a discrete period of time an amount of food larger than most people would eat in a similar amount of time under similar circumstances<jats:italic>and<\/jats:italic>a sense of lack of control over eating during the episode), occurring on average at least once a week for 3 months, and associated with marked distress. It can affect both men and women, regardless if they are at normal weight, overweight, or obese, and regardless of their ethnic or racial group. Psychiatric comorbidities are very common, with 79% of adults with BED also experiencing anxiety disorders, mood disorders, impulse control disorders, or substance use disorders; almost 50% of persons with BED have \u22653 psychiatric comorbidities. Multiple neurobiological explanations have been proffered for BED, including dysregulation in reward center and impulse control circuitry, with potentially related disturbances in dopamine neurotransmission and endogenous \u03bc\u2010opioid signaling. Additionally, there is interplay between genetic influences and environmental stressors. Psychological treatments such as cognitive behavioral interventions have been recommended as first line and are supported by meta-analytic reviews. Unfortunately, routine medication treatments for anxiety and depression do not necessarily ameliorate the symptoms of BED; however, at present, there is one approved agent for the treatment of moderate to severe BED\u2014lisdexamfetamine, a stimulant that was originally approved for the treatment of attention deficit hyperactivity disorder.<\/jats:p>","DOI":"10.1017\/s1092852915000772","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T15:19:24Z","timestamp":1450451964000},"page":"41-51","source":"Crossref","is-referenced-by-count":12,"title":["A primer on binge eating disorder diagnosis and management"],"prefix":"10.1017","volume":"20","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"S1092852915000772_ref50","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0901"},{"key":"S1092852915000772_ref49","unstructured":"Shire. Vyvanse (lisdexamfetamine dimesylate) positive top-line results in maintenance of efficacy study in adults with moderate to severe binge eating disorder. Press release. July 22, 2015. Available at: https:\/\/www.shire.com\/newsroom\/2015\/july\/vyvanse-positive-top-line-results-in-maintenance-of-efficacy-study-in-adults. Last accessed August 27, 2015."},{"key":"S1092852915000772_ref33","unstructured":"Cossrow N , Russo LJ , Ming EE , Witt EA , Victor TW , Wadden TA . Estimating the prevalence of binge eating disorder in a community sample comparing DSM\u2010IV\u2010TR and DSM\u20105 criteria. Poster presented at American Psychiatric Association 167th Annual Meeting; May 3\u20137, 2014; New York, NY."},{"key":"S1092852915000772_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20068"},{"key":"S1092852915000772_ref30","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-050212-185546"},{"key":"S1092852915000772_ref28","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/oby.2009.52","article-title":"Dopamine for \u201cwanting\u201d and opioids for \u201cliking\u201d: a comparison of obese adults with and without binge eating","volume":"17","author":"Davis","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"S1092852915000772_ref32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-292"},{"key":"S1092852915000772_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.05.002"},{"key":"S1092852915000772_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4679(198503)41:2<173::AID-JCLP2270410208>3.0.CO;2-N"},{"key":"S1092852915000772_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2004.06.011"},{"key":"S1092852915000772_ref26","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.27"},{"key":"S1092852915000772_ref36","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.62.3.199"},{"key":"S1092852915000772_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(199204)11:3<191::AID-EAT2260110302>3.0.CO;2-S"},{"key":"S1092852915000772_ref16","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(199111)10:6<627::AID-EAT2260100602>3.0.CO;2-4"},{"key":"S1092852915000772_ref15","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1987"},{"key":"S1092852915000772_ref13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/j.1550-8528.1993.tb00626.x","article-title":"Binge eating disorder: current knowledge and future directions","volume":"1","author":"Yanovski","year":"1993","journal-title":"Obes Res"},{"key":"S1092852915000772_ref12","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"S1092852915000772_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF01575455"},{"key":"S1092852915000772_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.12.063"},{"key":"S1092852915000772_ref10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0025-7125(16)35305-6","article-title":"Emotional aspects of obesity","volume":"35","author":"Hamburger","year":"1951","journal-title":"Med Clin North Am"},{"key":"S1092852915000772_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2009.05.001"},{"key":"S1092852915000772_ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12639"},{"key":"S1092852915000772_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2011.08.011"},{"key":"S1092852915000772_ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01449.x"},{"key":"S1092852915000772_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.11.020"},{"key":"S1092852915000772_ref38","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.8.713"},{"key":"S1092852915000772_ref42","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.333"},{"key":"S1092852915000772_ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2162"},{"key":"S1092852915000772_ref35","unstructured":"Shire. Binge Eating Disorder Screener-7 (BEDS-7). Available at: http:\/\/www.vyvansepro.com\/documents\/Adult-Binge-Eating-Disorder-Patient-Screener.pdf. Accessed August 27, 2015."},{"key":"S1092852915000772_ref29","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852915000462"},{"key":"S1092852915000772_ref41","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S25574"},{"key":"S1092852915000772_ref39","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1053465"},{"key":"S1092852915000772_ref34","unstructured":"Herman BK , Deal LS , DiBenedetti DB , Nelson L , Fehnel SE , Brown M . Development of the binge eating disorder screener. Poster presented at American Psychiatric Association 168th Annual Meeting; May 16\u201320, 2015; Toronto, ON."},{"key":"S1092852915000772_ref48","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12142"},{"key":"S1092852915000772_ref45","doi-asserted-by":"crossref","unstructured":"McElroy S , Hudson J , Ferreira-Cornwell MC , Radewonuk J , Gasior M . Randomized controlled safety and efficacy trials of lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder. Poster presented at American Psychiatric Association 167th Annual Meeting; May 3\u20137, 2014; New York, NY.","DOI":"10.1038\/npp.2015.275"},{"key":"S1092852915000772_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2005.10.006"},{"key":"S1092852915000772_ref27","doi-asserted-by":"publisher","DOI":"10.1017\/S146114570900039X"},{"key":"S1092852915000772_ref43","unstructured":"Shire. VYVANSE (lisdexamfetamine dimesylate) capsules, for oral use, CII. Prescribing information. Revised April 2015. Available at http:\/\/pi.shirecontent.com\/PI\/PDFs\/Vyvanse_USA_ENG.pdf. Last accessed August 27, 2015."},{"key":"S1092852915000772_ref37","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.61.2.296"},{"key":"S1092852915000772_ref19","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"S1092852915000772_ref6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/eat.20696","article-title":"Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder","volume":"43","author":"Vocks","year":"2010","journal-title":"Int J Eat Disord"},{"key":"S1092852915000772_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.040"},{"key":"S1092852915000772_ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01194.x"},{"key":"S1092852915000772_ref20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"S1092852915000772_ref9","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.09.2800"},{"key":"S1092852915000772_ref18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1098-108X(199303)13:2<137::AID-EAT2260130202>3.0.CO;2-#","article-title":"Binge eating disorder: its further validation in a multisite study","volume":"13","author":"Spitzer","year":"1993","journal-title":"Int J Eat Disord"},{"key":"S1092852915000772_ref40","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2014.879291"},{"key":"S1092852915000772_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.09.028"},{"key":"S1092852915000772_ref4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"S1092852915000772_ref3","doi-asserted-by":"publisher","DOI":"10.1002\/eat.20787"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852915000772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:59:35Z","timestamp":1718258375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852915000772\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":50,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1092852915000772"],"URL":"https:\/\/doi.org\/10.1017\/s1092852915000772","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}